RefleXion Showcases Pioneering Multi-Target Treatment (MTT) and Early Clinical Highlights at ASTRO @BusinessWire
RefleXion Showcases Pioneering Multi-Target Treatment (MTT) and Early Clinical Highlights at ASTRO @BusinessWire
BusinessWire | RefleXion Showcases Pioneering Multi-Target Treatment (MTT) and Early Clinical Highlights at ASTRO @BusinessWire | Uploaded September 2024 | Updated October 2024, 7 hours ago.
Sean Shirvani, M.D., chief medical officer at RefleXion, discusses the groundbreaking ability of SCINTIX therapy to accurately target tumors in a way that has never been done before.

MORE INFORMATION: businesswire.com/news/home/20240926318125/en/RefleXion-Showcases-Pioneering-Multi-Target-Treatment-MTT-and-Early-Clinical-Highlights-at-ASTRO
RefleXion Showcases Pioneering Multi-Target Treatment (MTT) and Early Clinical Highlights at ASTROReviving History: Shadowdock at the Birthplace of TitanicIncyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient...Hospitality Giant Revolutionizes Frontline Worker Experience with UKGAcreShield Completes Series A Funding, Increases Offering to Further AI Development to Provide ...AcreShield Completes Series A Funding, Increases Offering to Further AI Development to Provide ...HubSpot Launches New AI, Breeze, Plus Hundreds of Product Updates at INBOUND 2024Downy and Venus Williams Pair Up to Smash Tough Odor Out of LaundryBalmain Launches Balmain Beauty With a New Luxury Fragrance Collection: Les ÉternelsPromega Unveils GloMax® Galaxy Bioluminescence Imager for Illuminating Protein Dynamics in Real TimeTopps and Shohei Ohtani Sign Exclusive Long-Term Global Trading-Card Deal; Features Autograph...Wascomat Introduces the Toughest 200G Machine Yet, Now with Proven Touch Control Technology

RefleXion Showcases Pioneering Multi-Target Treatment (MTT) and Early Clinical Highlights at ASTRO @BusinessWire

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER